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Abstract Activation of caspases is recognized as a key element
in the apoptotic process. However, new evidence is drawing
attention to the emergent role of cell death pathways where
caspases are not involved. Recent advances in the molecular
understanding of these new ways to die, called caspase-indepen-
dent, have revealed that mitochondria play an important role via
the release of proapoptotic proteins. The purpose of this review
is to integrate, from a biological and structural point of view,
the most recent advances in the knowledge of the main mito-
chondrial proapoptotic proteins involved in this cell death cas-
cade. The origin of programmed cell death is discussed through
these strongly conserved e¡ectors.
 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
In multicellular organisms, programmed cell death (PCD,
apoptosis) is a genetically regulated mechanism that plays a
crucial role in the control of normal development and in the
regulation of tissue homeostasis [1]. Failure to accurately
undergo apoptosis can cause severe anomalies, ranging from
autoimmune diseases to cancer [2]. In the last decade, much of
the attention in the study of PCD was focused on caspases, a
family of cysteine proteases speci¢cally activated in apoptotic
cells [3]. However, cell death can still occur even when the
caspase cascade is blocked [4]. This fact has revealed the ex-
istence of alternative pathway(s) de¢ned as caspase-indepen-
dent [5,6].
The induction of mitochondrial membrane permeabilization
(MMP), which is controlled by the Bcl-2 family of proteins, is
a critical event in apoptosis. Most pathways upstream of
MMP are caspase-independent, and both caspase-dependent
and caspase-independent paths become possible after mito-
chondrial damage. In classical apoptosis (caspase-dependent),
after MMP induction cytochrome c redistributes from mito-
chondria to cytosol to activate caspase-9, in collaboration
with ATP and the cytosolic factor Apaf-1 [3]. In other mech-
anisms implicating caspases and mitochondria, caspase-inhib-
itory factors are separated from their physiological partners
by mitochondrial proteins such as Smac/DIABLO1 or Omi/
HtrA2, resulting in caspase activation [7]. The intermembrane
space of mitochondria also contains other proteins, such as
AIF and EndoG, which can provoke PCD in a caspase-inde-
pendent manner [8]. Finally, Omi/HtrA2 can build a shuttle
between caspase-dependent and -independent PCD through
its serine protease activity [9]. Therefore, the mitochondrion
is not only the cell’s powerhouse, but also a weapon store
where a cocktail of caspase-dependent or -independent pro-
apoptotic proteins are sequestered until death is triggered
[10,11]. The present review aims to integrate the current
knowledge about the mitochondrial molecules involved in cas-
pase-independent cell death (CICD), a highly orchestrated
form of cell death.
2. Apoptosis-inducing factor
AIF was identi¢ed and cloned in 1999 as a protein released
from the mitochondrial intermembrane space during the apo-
ptotic process [12]. Initial studies have shown that upon an
apoptotic stimulus AIF translocates, in a Bcl-2-controlled
fashion, from mitochondria to cytosol and further to the nu-
cleus where it triggers chromatin condensation as well as
large-scale (V50 kb) DNA fragmentation [12]. AIF has also
a direct e¡ect on both isolated nuclei and puri¢ed mitochon-
dria where it provokes the release of caspase-9, thereby sug-
gesting a possible link between AIF and the caspase-depen-
dent pathway [12]. The physiological relevance of AIF was
emphasized in the work published in 2001 by Joza et al.
[13]. In this paper the authors showed that aif3=Y embryonic
stem cells were unable to form cystic embryonic bodies. This
fact suggests an essential function of AIF in mouse develop-
ment [13].
AIF is expressed as a precursor of 67 kDa. This form is
addressed and compartmentalized in mitochondria by two
mitochondrial localization sequences located within the N-ter-
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minal prodomain. Once in mitochondria, the full-length AIF
is processed and the prodomain removed, giving rise to a
mature form of V57 kDa [12]. AIF consists of three struc-
tural domains: (i) FAD-binding domain, (ii) NAD-binding
domain, and (iii) C-terminal domain (Fig. 1A) [14]. The oxi-
doreductase part of AIF (composed of both NAD- and FAD-
binding moieties) confers an electron transfer activity to the
protein that has been fully con¢rmed in functional assays. In
vitro, AIF produces superoxide free radicals as it exhibits
NADH oxidase activity catalyzing the reduction of O2 to
Oc32 [15]. The measured rate of AIF electron transfer, from
NADH to O2, is very low [15]. If this rate is similar inside the
mitochondria, it is di⁄cult to conceive both the natural elec-
tron acceptor of AIF and the physiological relevance of the
redox function of the protein. However, the compartmentali-
zation of the protein in the mitochondrion could completely
change this redox behavior. The ability of AIF to produce
superoxide free radicals apparently contrasts with the data
obtained by Ackerman’s group in the Harlequin mouse [16].
In this model, cerebellar granule cells obtained from Harle-
quin mutant mice were more susceptible to peroxide-induced
apoptosis when compared with cerebellar granule cells from
wild-type mice. Retroviral transfection of AIF eliminates this
di¡erence, leading the authors to suggest that AIF acts as a
free radical scavenger to prevent apoptosis [16]. Then, what is
the true redox function of AIF, promoter or scavenger of free
radicals? Probably both, as it seems logical to expect AIF
behavior to vary according to the protein location. On the
one hand, AIF could accomplish some free radical scavenger
activity inside mitochondria either via the reduction of a yet
unidenti¢ed compound present in the intermembrane space or
by taking part in the mitochondrial electron transfer chain.
This last idea is supported by a recent proteomic study that
identi¢ed the presence of AIF in a puri¢ed fraction of the
complex IV of the mitochondrial oxidative phosphorylation
system [17]. However, many traditional experiments carried
out with submitochondrial particles, proteoliposomes or puri-
¢ed enzyme did not consider AIF to have an important role in
the mitochondrial cytochrome oxidase activity. On the other
hand, a di¡erent behavior of AIF seems possible when the
Fig. 1. A: Ribbon structure of AIF showing the three domains of the protein: FAD-binding domain in magenta, NAD-binding domain in
green, and C-terminal domain in yellow. B: Model of the theoretical interaction between the dimeric form of AIF and the DNA (id 1GV4).
C: Phylogenetic tree representing the relationship between AIF and other oxidoreductases from di¡erent species. Note the proximity of the
AIF family (red branch) to the NADH-oxidase family from Archaea (blue branch). The PIR accession codes are enumerated following the ab-
breviation of each specie: AA: Aquifex aeolicus ; AC: Acinetobacter calcoaceticus ; AF: Archaeoglobus fulgidus ; AT: Arabidopsis thaliana ; BC:
Burkholderia cepacia ; BS: Bacillus subtilis ; CE: Caenorhabditis elegans ; DD: Dictyostelium discoideum ; DM: Drosophila melanogaster ; EC: Es-
cherichia coli ; HS: Homo sapiens ; LS: Lycopersicon esculentum ; MJ: Methanocaldococcus jannaschii ; MM: Mus musculus ; MTH: Methanobac-
terium thermoautotrophicum ; NA: Novosphingobium aromaticivorans ; PF: Pseudomonas £uorescens ; PH: Pyrococcus horikoshii ; PO: Pseudomo-
nas oleovorans ; PP: Pseudomonas putida ; PS: Pseudomonas sp.; PSA: Pisum sativum ; SP: Schizosaccharomyces pombe ; SS: Sphingomonas sp.;
RE: Rhodococcus erythropolis ; RG: Rhodococcus globerulus ; XL: Xenopus laevis.
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protein is released from mitochondria. Once in the cytosol, it
is feasible to believe that AIF could associate with di¡erent
partners to produce the free radicals observed in the in vitro
assays. In any case, in vivo models such as the Harlequin
mouse and the aif3=Y embryonic stem cells are ideal tools
to investigate the importance of AIF in cell survival. Indeed,
it is possible to compare the respiratory pathways and the
electron chain transport occurring in mitochondria puri¢ed
from Harlequin and wild-type mice. The same study, also
possible in aif3=Y and aifþ=Y embryonic stem cells, can de¢n-
itively close this still theoretical issue.
The C-terminal domain of AIF is the most intriguing part
of the protein, given the absence of signi¢cant homology with
any other protein. Deletion of this domain abrogates the
apoptogenic activity of AIF, suggesting an essential role in
the death function [12]. A structural analysis of the C-terminal
domain of AIF showed that a long insertion resulting in a
£exible loop resides in this part of the molecule. This region
contains a PEST motif (usually involved in processes of pro-
tein degradation) that could explain the disappearance of AIF
from the cytosol observed in activated T lymphocytes [18].
Interestingly, in the AIF form of Dictyostelium discoideum,
the PEST motif switches over the N-terminal part of the mol-
ecule [19]. In addition, the extended structure of the C-termi-
nal loop could also suggest a potential binding region for
some chaperones, such as Hsp70, which has been shown to
interact with AIF and impair its apoptotic function [20].
However, a recent work suggests that Hsp70 interacts with
the N-terminal domain of the protein [21]. In this region,
two amino acids that are present in the human protein,
R192 and K194, seem to be essential for the link [21]. Intrigu-
ingly, the C-terminal region of AIF also contains an RNA-
binding motif (aa 549^567) which is typical of some ribosomal
proteins and suggests a possible binding of AIF to RNA.
Unlike this theoretical AIF^RNA interaction, the AIF^
DNA interaction has been recently demonstrated [22]. In a
¢rst model, structural analysis of monomeric human AIF re-
veals a strong positive electrostatic charge that might be in-
volved in the interface of interaction with DNA [22]. The
interface begins from a pocket between NAD and the C-ter-
minus, and extends to one face of the C-terminal domain. In a
parallel work, mouse AIF was crystallized in a dimeric form
that creates a deep groove where some of the best conserved
basic residues are located [14]. Given its dimensions, we are
tempted to speculate that this groove could serve to accom-
modate a double-stranded DNA molecule (Fig. 1B). Under
these conditions, the recruitment of other potential partners
such as nucleases, topoisomerases, or cyclophilins might help
AIF to complete its DNA degradation function.
Summing up, AIF is a dual-function protein that deals with
events of life and death. Con¢ned in mitochondria from
healthy cells, AIF could be essential for cell survival through
its redox function, as suggested by the work performed in the
Harlequin mouse. In contrast, when AIF is released from
mitochondria in apoptotic conditions, it triggers cell death
either directly, through interaction with DNA, or indirectly,
through reactive oxygen species production [23].
3. Endonuclease G
Eukaryotic EndoG is a divalent cation-dependent endonu-
clease described in chicken erythrocytes in 1987 [24]. EndoG is
encoded by a nuclear gene and is mainly associated with
functions in DNA repair or mitochondrial DNA (mtDNA)
duplication. Their prokaryotic homologs has been implicated
in metabolic scavenging functions and virulence.
EndoG is a sequence-unspeci¢c DNase that shows great
a⁄nity for kinked DNA at low levels. The degradation of
DNA produced by this enzyme gives rise to fragments with
nicks at 5P-P and 3P-OH ends. In addition, EndoG also has
RNase activity, which generates the RNA primers required by
DNA polymerase Q to initiate replication of mtDNA.
Other than its function in mtDNA replication, a new role in
the apoptotic process has been assigned to EndoG. Two ele-
gant studies disclosed EndoG’s ‘double life’, as it is the case
for other apoptogenic proteins (i.e. AIF, cytochrome c, and
Omi/HtrA2) [25,26]. These works demonstrated that upon ap-
optotic stimulus (including tBid, Bax, calcium and chemother-
apeutic drugs), EndoG translocates from mitochondria to nu-
cleus, where extensively degrades nuclear DNA into
oligonucleosomal fragments, similar to those generated by
the caspase e¡ector CAD (caspase-activated DNase). These
works also demonstrated that CAD and EndoG activities
are independent, since EndoG does not require prior caspase
processing for its activation. Intriguingly, recent results sug-
gest that caspases seem to have some role on the translocation
of EndoG (and AIF) from mitochondria to cytosol through
an unknown mechanism regulated by the proapoptotic mem-
bers of the Bcl-2 family Bax and Bak [27]. This work provided
another link between the Bcl-2 family of proteins, mitochon-
dria and their control of caspase-dependent and -independent
cell death pathways.
EndoG, which belongs to an important family of Mg2þ-
dependent nucleases [28] (Fig. 2A), is synthesized as a precur-
sor ofV30 kDa. After mitochondrial import, the N-terminal
region of 48 amino acids is removed yielding the mature form.
Structural studies in the homologous of the endonuclease
from Serratia marcescens revealed a homodimer with two di-
sul¢de bonds that provide high stability and resistance to
reduction and to chaotropic agents [28] (Fig. 2). The homolog
of EndoG is built in an original folding that consists of a
central six-stranded antiparallel L-sheet £anked by K-helices
on both sides (Fig. 2B). Each monomer contains a catalytic
site that is highly conserved throughout all the species studied
(Fig. 2A). Enzymological analysis of this homolog reveals two
critical residues for its nuclease activity: (i) H89, which could
act as general base activating a nucleophilic water molecule
responsible for the DNA cleavage, and (ii) N119, which di-
rectly binds Mg2þ (Fig. 2B). Point mutations in each one of
these residues abrogate the nuclease activity [28].
Genetic studies performed in Caenorhabditis elegans provide
clear evidence for an important role of the EndoG ortholog
cps-6 in the breakdown of DNA during developmental cell
death [26]. Using RNAi techniques (or reduction of cps-6
activity by a genetic approach) the authors showed that dur-
ing C. elegans development, the appearance of cell corpses
was delayed by the downexpression of CPS-6. Another im-
portant issue involved in a thorough understanding of CICD
emerges from a recent work also performed in C. elegans [8].
In this organism, CPS-6 binds and acts synergistically with
WAH-1 (the AIF ortholog in C. elegans). These ¢ndings
demonstrate that AIF and EndoG can cooperate, thereby
highlighting the importance of both molecules in PCD execu-
tion.
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4. Omi/HtrA2, an e¡ector with dual apoptotic activity
Identi¢ed in 2000, Omi/HtrA2 is a 50 kDa mammalian
serine protease that shares signi¢cant homology with the bac-
terial endoprotease HtrA [29,30]. In bacteria, the protein has a
chaperone function and helps to degrade or refold proteins in
the periplasmic space. In mammals, Omi/HtrA2 is a ubiqui-
tous protein with a dual proapoptotic function [31].
Omi/HtrA2 is a nuclear-encoded mitochondrial protein syn-
thesized as a proenzyme of 458 amino acids. After mitochon-
drial import, 133 N-terminal residues of the protein are re-
moved to generate an active form of 36 kDa. The resulting
molecule exposes an amino-terminus (AVPS motif) that
shares high homology with Drosophila Grim, Hid, Reaper,
and mammalian Smac/DIABLO proteins. The AVPS tetra-
peptide motif consists in a short stretch of hydrophobic amino
acids that competitively bind the baculoviral IAP repeat do-
main of inhibitor of apoptosis proteins (IAPs) [31]. In phys-
iological conditions, Omi/HtrA2 is con¢ned in mitochondria
and kept away from IAPs. Upon apoptotic stimulus, the ma-
ture form is released to the cytoplasm to bind IAPs. The
interaction between Omi/HtrA2 and IAP disrupts the IAP^
caspase inhibitory complex and results in caspase activation.
In this sense, the caspase activation mechanism prompted by
Omi/HtrA2 resembles to that triggered by Smac/DIABLO,
which also binds IAPs and subsequently activates caspase-9
[32,33]. Omi/HtrA2 can also induce apoptosis in a caspase-
independent manner that seems linked to its serine protease
activity [31].
The topology of mature Omi/HtrA2 comprises seven K-heli-
ces and 19 L-strands, forming two domains: the catalytic ser-
ine protease domain and the PDZ domain (Fig. 3A). The
catalytic domain of Omi/HtrA2 is located in the central region
of the molecule, while the PDZ domain, which regulates the
serine protease activity, is located in the C-terminal region.
PDZ domains are known to bind four or ¢ve residues of their
target proteins through a hydrophobic cleft composed of a L-
strand, an K-helix and a loop that binds the peptide carbox-
ylate group. The crystal structure of Omi/HtrA2 has also re-
vealed that the formation of a pyramid-shaped homotrimer is
a prerequisite for the caspase-independent function of the
protein [34] (Fig. 3B). Mutational analysis con¢rms that
monomeric Omi/HtrA2 is unable to induce cell death when
its serine protease activity is seriously impaired. A model for
Omi/HtrA2-induced apoptosis suggests that the PDZ domains
of oligomeric Omi/HtrA2 block access to the catalytic site
until recognition of the substrate. Contact with the partner
provokes a conformational change that induces exposure of
the substrate-binding sites of the protease and results in a
cleavage of the substrate [34] (Fig. 3B).
The functional signi¢cance of Omi/HtrA2 was greatly
underlined after a recent work that examined its role in the
Fig. 2. A: Amino acid sequence alignment of nucleases homologous to EndoG in the region containing the catalytic site. Note the strict conser-
vation of the essential residues. B: Ribbon diagram of the homolog from Serratia marcescens. Catalytic residues are colored in magenta.
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mouse mutant mnd2 (motor neuron degeneration 2) [35]. In
this work, the authors showed that the point mutation S276C
provokes neuronal degeneration as well as juvenile lethality.
Loss of the caspase-independent activity of Omi/HtrA2 also
provokes mitochondrial alterations and increases sensitivity to
cellular stress. In addition, two recent studies could shed con-
siderable light on the mechanism employed by this protein to
induce CICD. On the one hand, a speci¢c inhibitor of their
caspase-independent activity, named ucf-101, has been identi-
¢ed [36]. This inhibitor can be used as a tool to di¡erentiate
the two proapoptotic activities of the protein and their con-
tribution to PCD. On the other hand, the optimal substrate
sequence for cleavage by Omi/HtrA2 has been identi¢ed: a
crucial ¢nding to better understand the regulation and the
function of this dual protein [37].
5. New arrivals in the family of mitochondrial caspase-
independent e¡ectors
The avalanche of fruitful investigations in the domain of
PCD constantly adds new proteins to the list of molecules
involved in caspase-independent events. In 2001 Chang et al.
reported a new proapoptotic oxidoreductase activity that was
named WOX1 [38]. This protein, also called WWOX or FOR
[39] [40], bears two WW domains in its N-terminal sequence.
Eight spliced forms have been described, of which WOX1
(WWOX, FOR2, or v1) is the full-length protein [41]. This
protein exhibits many interesting properties. For example,
WOX1 enhances the tumor necrosis factor-K (TNFK) apopto-
tic responsiveness via downregulation of antiapoptotic Bcl-2
molecules, upregulation of proapoptotic p53 or by interaction
with molecules downstream of the TNF receptor, such as
TRAF2 and TRADD. A portion of WOX1 is con¢ned in
mitochondria from ¢broblasts in physiological conditions.
Upon apoptotic stimuli (i.e. TNFK, staurosporine), WOX1
is released from mitochondria to the cytosol and to the nu-
cleus, a translocation that seems to be dependent on the phos-
phorylation at Y33. In addition, WOX1 physically interacts
with p53 and induces apoptosis in a synergistic manner, since
siRNA knockdown of WOX1 abrogates p53 apoptosis. The
proposed interface of binding involves the interaction of the
WW domains of WOX1 with the proline-rich region of p53.
Besides, phosphorylation of S46 in p53 and both Y33 and
Y61 in WOX1 is required for such interaction to take place.
In addition, the discovery that WOX1 can also interact with
c-Jun N-terminal kinase 1 (JNK1) introduced a high level of
complexity to this system. In fact, UV stress induces WOX1
phosphorylation at Y33 as well as activation of p53 and
JNK1, suggesting the formation of a heterotrimeric complex
of WOX1/JNK1/p53 [41]. The diversity of pathways in which
WOX1 is involved turns them into a very attractive ¢eld of
research. Hopefully, future works will respond to the unan-
swered questions concerning the involvement of WOX1 in
redox functions, for example, or the relationship among the
di¡erent WOX spliced forms.
In 2002 two homologs of the mature form of AIF were
simultaneously reported: AMID [42] and PRG3 [43]. Both
proteins share an identical amino acid sequence, but the au-
thors have reported signi¢cant di¡erences. AMID is mainly
localized in the outer mitochondrial membrane, while PRG3
resides in the cytosol. In addition, AMID-induced apoptosis is
independent of caspases and p53, while PRG3 expression trig-
gers p53- and caspase-dependent cell death. A more detailed
analysis seems necessary to determine the relationship among
the di¡erent AIF spliced forms and their physiological rele-
vance.
Very recently, a human homolog of the Drosophila spin
gene product, called HSpin1, was identi¢ed [44]. This protein
is localized in mitochondria and released to cytosol after
TNFK treatment. HSpin1 binds to Bcl-2 and Bcl-Xl probably
Fig. 3. A: Ribbon structure of Omi/HtrA2. The catalytic residues are represented in red and the PDZ domain in magenta. B: Model for the
trimeric form of Omi/HtrA2. The IAP-binding domains of each of the three monomers are colored in yellow, blue and green, respectively. All
PDZ domains are colored in magenta. Recognition of the substrate would drive a conformational change where the PDZ domains open up (ar-
rows) to expose the catalytic site (red balls), resulting in cleavage of the substrate.
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to modulate their antiapoptotic e¡ects. The authors also
found that the HSpin1-induced cell death was abrogated by
the necrotic inhibitor pyrrolidine dithiocarbamate, but not by
the broad-range caspase inhibitor z-VAD.fmk. This fact sug-
gests an atypical caspase-independent apoptosis with some
necrosis-like characteristics. Furthermore, HSpin1 expression
can induce accumulation of monodansylcadaverine (a speci¢c
marker for autophagic vacuoles) as well as maturation of ca-
thepsin D. Taken together, these data strongly suggest that
HSpin1 is involved in a necrotic-like or autophagic cell death
pathway that acts in a caspase-independent manner.
6. Evolutionary considerations of caspase-independent cell
death
Evolution of life on earth underwent critical transitions that
gave rise to the origin of eukaryotes and the advent of multi-
cellularity [45]. These evolutionary steps involved the develop-
ment of innovative functional mechanisms such as cell cycle
regulation or PCD. Initial phylogenetic studies of apoptosis
basically suggest that caspases are proteins from highly
evolved apoptotic systems. In contrast, caspase-independent
molecules belong to older systems that emerged before the
birth of the eukaryotic cell. The recent discovery of metacas-
pases and paracaspases, also present in prokaryotes, could
contravene this hypothesis if their implication in cell death
processes is con¢rmed.
AIF is a highly conserved protein ubiquitously present in all
primary kingdoms, Bacteria, Archaea and Eucaryota (Fig.
1C). Its phylogenetic study has some constraints because
AIF orthologs have a well-recognized pyridine nucleotide^di-
sul¢de oxidoreductase domain, found in a large number of
non-apoptotic proteins, which can mask or alter the scores
of the apoptotic motifs in databases. As opposed to EndoG
and Omi/HtrA2, AIF is strongly represented in Archaea.
Among eukaryotes, a strong homology is seen in plant ascor-
bate reductases (i.e. Arabidopsis thaliana, Cucumis sativus or
Lycopersicon esculentum) [46] (Fig. 1C). Intriguingly, as is the
case in mammalian AIFs, dehydroascorbate reductase activity
has been reported to redistribute from mitochondria to the
cytosol in the dark-induced senescence of Pisum sativum
[46]. AIF also has a highly signi¢cant homology with di¡erent
families of oxidoreductases, from Archaea and Bacteria to
invertebrates and vertebrates. In a recent work, Koonin and
Aravind [47] concluded that AIF is the unique known element
of the apoptotic machinery that obeys the rules of standard
evolution. Academically, this means that the aif gene is inher-
ited from the last universal common ancestor and follows the
tree topology with the primary radiation of the archaeo-eu-
karyotic and bacterial clades. Basically, if the implication of
AIF orthologs in death processes is con¢rmed, the apoptosis
triggered by AIF could represent the oldest way to die.
From a phylogenetic point of view, EndoG is a strongly
conserved protein present in eukaryotes and prokaryotes,
such as Proteobacteria and Cyanobacteria, but absent in Ar-
chaea. Although the implication of EndoG in the apoptotic
process has been fully demonstrated only in mammals and C.
elegans, ladders of fragmented DNA have been observed in
their respective EndoG orthologs in plants, fungi and proto-
zoa. Further studies would be necessary to determine if the
nuclease activity of these orthologs is involved in cell death.
Phylogenetic analysis of the HtrA2 family strongly supports
the mitochondrial endosymbiosis theory and a mitochondrial
origin of the eukaryotic HtrA2-like proteases. As a protein
with ancient evolutionary origins, it probably has an impor-
tant housekeeping function in protein refolding and in degra-
dation within mitochondria. Omi/HtrA2 exhibits an evolu-
tionary pattern that is similar to EndoG’s. According to the
studies of Koonin and Aravind, Omi/HtrA2 is present in Bac-
teria with the exception of mycoplasms [47]. Omi/HtrA2, like
EndoG, is also absent in Archaea but present in K-Proteobac-
teria, following the most widely accepted model of the mito-
chondrial origin of eukaryotic proteins [48].
Despite their well-di¡erentiated mechanisms, caspase-de-
pendent and -independent pathways may operate together
(or in parallel) in eukaryotic cells. This apparent redundancy
ensures the cell suicide once the decision of death has been
made. More studies in di¡erent species are required in order
to understand the evolution of these pathways. Particularly,
the study of their putative implication in bacterial pathogen-
esis is a very promising ¢eld of research. It would be very
interesting to study the functional implication of the homo-
logs of caspase-independent or caspase-dependent systems
(paracaspases, metacaspases) in the mechanisms of cell suicide
or bacteria-induced toxicity. The evolutionary cell death sce-
nario, set up through the structural analysis of the mitochon-
drial proapoptotic proteins, suggests that the eukaryotic cell
originated when bacteria were captured by a proto-eukaryotic
cell. The modern eukaryotic cell seems to be the legacy of this
ancestral symbiotic relationship between the proteobacterium
and its host: today both are destined to live together in mu-
tual cooperation for life and death.
7. Concluding remarks
The existence of multiple programs of cell death is strongly
supported by the vast amount of information disclosed in
recent years. It is clear that CICD e¡ectors may also perform
critical functions for cell survival. In this context, the general
analysis of caspase-independent pathways of death is a new
challenge for researchers. Further studies are necessary to
understand their biological relevance and their implication
in pathological processes. In any case, it seems clear that a
full understanding of the regulation of CICD could provide
new means of improving current diagnosis and promoting
conceptual advances for the design of new therapeutic strat-
egies.
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